Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

• Status: Completed
• Trial end date: 2016-08-30
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice setting.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Iodine

Criteria

Inclusion Criteria:

• All children age 0-3 years (inclusive) who are identified of having undergone a radiological examination with intravascular use of an iodinated contrast agent.(e.g.

contrast enhanced CT, cardioangiography)

Exclusion Criteria:

• Congenital Hypothyroidism or other forms of preexisting hypothyroidism

• Preexisting thyroid hormone replacement therapy less than three months of observation before the radiological examination (if greater than three months old)

• Less than two weeks follow-up available after the contrast exposure.